The Journal of Neuroscience, 2003 · DOI: · Published: February 15, 2003
Injuries to the central nervous system (CNS) often result in limited axon regeneration due to the presence of inhibitory molecules. This study focuses on the role of Rho GTPases, which regulate actin rearrangements in growth cones, in this inhibition. The researchers found that Nogo-66, a myelin-associated inhibitor, directly activates Rho. By inhibiting Rho or its downstream effector ROCK, they aimed to promote neurite outgrowth and axonal regeneration. The study demonstrates that inhibiting ROCK with Y-27632 enhances sprouting of corticospinal tract (CST) fibers in vivo and accelerates locomotor recovery after CST lesions in adult rats, suggesting a potential therapeutic strategy for spinal cord injuries.
ROCK inhibition with Y-27632 shows promise as a therapeutic strategy for promoting axonal regeneration and functional recovery after spinal cord injury.
Targeting the Rho pathway, specifically ROCK, may overcome the inhibitory effects of multiple myelin-derived inhibitors, providing a broad approach to promoting regeneration.
Development of more potent and selective ROCK antagonists could lead to more effective treatments for spinal cord injury.